Search clinical trials for: Fluorouracil (5-FU)

Total 16427 results

Catharina Ziekenhuis Eindhoven

Recruiting

Therapeutic Oncolytic Monitoring as a Tool for Effective Exposure to 5-FU in Patients With Locally Advanced, Resectable Gastric or Gastro-oesophageal Junction Cancer Treated With Perioperative FLOT (THOMAS FU FLOT)

TDM of 5-FU | Pharmacokinetic Observational Study

Netherlands
Sun Yat-sen University
Guangzhou No.12 People's Hospital; Kaiping Central Hospital

Unknown

HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

HepatoCellular Carcinoma

China
Yun-fei Xia

Unknown

A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

Nasopharyngeal Carcinoma

China
Accelerated Community Oncology Research Network
InterMune

Completed

Study of Gamma Interfereon in Metastatic Colorectal Carcinoma (GFL)

Colorectal Cancer

United States
Galectin Therapeutics Inc.

Withdrawn

A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer

Colorectal Cancer

Israel
Italian Trial in Medical Oncology

Completed

Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC) (P2)

Hepatocellular Carcinoma

Italy
Sanofi
Regeneron Pharmaceuticals

Completed

Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer

Neoplasm Metastasis | Colorectal Neoplasms

Japan
Brown University
The Miriam Hospital; Rhode Island Hospital

Terminated

A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer (276)

Anal Cancer

United States
Shanghai Jiao Tong University School of Medicine

Recruiting

Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage

Carcinoma, Squamous Cell | Mouth Neoplasms

China
Leiden University Medical Center
Erasmus Medical Center; The Netherlands Cancer Institute; Medical Center Haaglanden and other collaborators

Unknown

Identifying Novel Variants in the DPYD Gene in Patients of Non-Western Descent (DPYD-NOW)

Neoplasms
Dong-A University Hospital

Completed

FOLFIRINOX for 2nd-line Treatment of BTC

Biliary Tract Cancer

Korea, Republic of
University of Utah

Terminated

Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma

Cancer

United States
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Completed

A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis

Neoplasm Metastasis | Gastric Cancer

Japan
Saladax Biomedical, Inc.

Completed

Retrospective Evaluation of 5-FU Exposure Optimization in CRC Patients (5-FU RECORD)

Metastatic Colorectal Cancer | Adjuvant Colorectal Cancer | 5-FU Containing Therapy Regimens

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
Eleison Pharmaceuticals LLC.

Recruiting

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

Metastatic Pancreatic Adenocarcinoma

United States
Luye Pharma Group Ltd.

Completed

Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors

Advanced Solid Tumor

China
The Netherlands Cancer Institute
Leiden University Medical Center

Unknown

Improving the Safety of Fluoropyrimidine-based Chemotherapy (Alpe2U)

Neoplasms

Netherlands
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital

Completed

Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

United States
National Taiwan University Hospital
National Health Research Institutes, Taiwan

Completed

Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

Taiwan
Belgian Group of Digestive Oncology
University Hospital St Luc, Brussels

Recruiting

A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC) (NALPAC)

Metastatic Pancreatic Ductal Adenocarcinoma

Belgium
Zhongshan Ophthalmic Center, Sun Yat-sen University

Unknown

Evaluation of Filtering Bleb After Glaucoma Surgery by AS-OCTA (AS-OCTA)

Trabeculectomy
Pfizer

Completed

Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer

Liver Neoplasms | Colorectal Neoplasms

United Kingdom, Germany, Ukraine, France, Korea, Republic of, Belgium, Spain, Hong Kong, Switzerland, Italy, Israel, Sweden, Denmark, Portugal, South Africa, Taiwan
Astellas Pharma Global Development, Inc.

Recruiting

A Study to Assess the Antitumor Activity, Safety, Pharmacokinetics and Biomarkers of Zolbetuximab (IMAB362) in Participants With Claudin (CLDN) 18.2 Positive, Metastatic or Advanced Unresectable Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma and Locoregional Gastric or GEJ Adenocarcinoma (ILUSTRO)

Gastric Cancer | Pharmacokinetics of Zolbetuximab | Gastro-esophageal Junction (GEJ) Cancer | Pharmacokinetics of Oxaliplatin | Pharmacokinetics of Fluorouracil Bolus (5-FU)

United States, Japan, Italy, Korea, Republic of, Taiwan, France
Institut für Klinische Krebsforschung IKF GmbH...
Sanofi; Trium Analysis Online GmbH; STABIL - Statistische und Biometrische Lösungen

Completed

Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer (ELDERLY)

Colorectal Cancer

Germany
Assistance Publique Hopitaux De Marseille

Completed

Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy (5-FU)

Patients With Head and Neck Cancer (ORL)

France
University Hospital of Crete

Terminated

Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc

Colorectal Cancer

Greece
M.D. Anderson Cancer Center

Completed

Primary Breast Cancer Occurring Concomitant With Pregnancy

Breast Cancer | Pregnancy

United States
Clinical Oncology Research Associates

Withdrawn

Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy

Carcinoma, Non-Small-Cell Lung

United States
Shahid Beheshti University of Medical Sciences

Unknown

Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)

Proliferative Vitreoretinopathy

Iran, Islamic Republic of
Sol-Gel Technologies, Ltd.

Completed

Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream

Actinic Keratosis (AK)

United States
University of Massachusetts, Worcester

Completed

A Trial of Chemo & Radiation Therapy for Pancreatic Cancer

Pancreatic Cancer
Sanofi
Regeneron Pharmaceuticals; NSABP Foundation Inc

Completed

Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen (VELOUR)

Neoplasm Metastasis | Colorectal Neoplasms

Italy, Austria, Estonia, Spain, South Africa, Belgium, Puerto Rico, United Kingdom, Sweden, United States, Argentina, Australia, Brazil, Chile, Czech Republic, Denmark, France, Germany, Greece, Korea, Republic of, Netherlands, New... and more
The University of Hong Kong
Health and Medical Research Fund; Primary Healthcare Office, Hong Kong

Recruiting

Evaluation of the Chronic Disease Co-Care Pilot Scheme

Hypertension | Diabetes Mellitus, Type 2 | Chronic Disease | Disease Management | Primary Healthcare

Hong Kong
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies

Solid Tumor

United States
Memorial Sloan Kettering Cancer Center

Completed

Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer

Gastric Cancer | Esophageal Cancer

United States
Carilion Clinic

Recruiting

Combination 5-FU / Calcipotriene Cream for SCCIS/SCC

Squamous Cell Carcinoma

United States
National Taiwan University Hospital
Taipei Veterans General Hospital, Taiwan; National Cheng-Kung University Hospital

Completed

Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer

Metastatic Gastric Cancer

Taiwan
Shahid Beheshti University of Medical Sciences

Unknown

Comparison of Subconjunctival 5-Fluorouracil (FU) Injection and Mitomycin C for Treatment of Early Bleb Failure

Bleb

Iran, Islamic Republic of
Jiangsu HengRui Medicine Co., Ltd.

Completed

Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic Cancer

Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy

China
Mast Therapeutics, Inc.

Unknown

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Metastatic Colorectal Cancer | Rectal Cancer | Colon Cancer

United States, Former Serbia and Montenegro
Andrew Ko
Infinity Pharmaceuticals, Inc.

Completed

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

Adenocarcinoma | Pancreatic Neoplasms | Pancreatic Cancer

United States
Eastern Hepatobiliary Surgery Hospital

Completed

Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma | Portal Vein Tumor Thrombus

China
Symphogen A/S

Completed

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

France, Spain, United States, Belgium, Germany, Italy, Russian Federation, Hungary, Poland, Austria
Technische Universität Dresden

Completed

Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)

Colorectal Cancer | Liver Metastases

Germany, Austria
Spanish Cooperative Group for the Treatment of...
Sanofi

Completed

Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen (AFEMA)

Metastatic Colorectal Cancer

Spain
Eli Lilly and Company
Bristol-Myers Squibb

Completed

Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer

Colorectal Cancer

United States
Dana-Farber Cancer Institute
Bristol-Myers Squibb; Massachusetts General Hospital; Beth Israel Deaconess Medical... and other collaborators

Terminated

Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

Rectal Cancer

United States
Dana-Farber Cancer Institute
Bristol-Myers Squibb; Brigham and Women's Hospital

Completed

C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Head and Neck Neoplasms

United States
Merrimack Pharmaceuticals

Completed

Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer (NAPOLI-1)

Metastatic Pancreatic Cancer

United States, France, United Kingdom, Germany, Taiwan, Spain, Argentina, South Africa, Korea, Republic of, Canada, Brazil, Czech Republic, Hungary, Italy, Australia

Search clinical trials for: Fluorouracil (5-FU)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations